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The most ideal way to produce cloned pigs to date is SCNT. Due to 
comparative simplicity of overexpression than gene KO, lots of target gene 
overexpressed pigs have been produced while less KO pigs were reported. 
Recently, diverse genetic scissors (i.e., ZFN, TALEN or RGEN), which 
rapidly increase the number of KO animals including pigs have been started 
to highlight. 
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Pigs are considered to be an important large animal model in biomedical 
research. Due to absence of porcine ESCs and characterized cell lines, 
development velocities of genetic modification technologies and transgenic 
pig production are tardy. In this study, to overcome absence of characterized 
cell lines, hTERT genes overexpressing immortalized cell lines were 
established and characterized. These cells were further used to apply genetic 
modification technology (i.e., KO by TALEN). The gene overexpression 
and KO technologies were respectively applied for genetic modified pig 
production (i.e., Neurodegenerative disorder pig model). 
For immortalizing porcine cells, primary porcine fetal fibroblasts were 
isolated and cultured using the hTERT transfection. After selecting cells 
with neomycin for two weeks, outgrowing colonized cells were picked up 
and sub-cultured for expansion.  
Various analyses were accomplished and characterized for confirming 
target gene insertion in cells. Immortalized cells were cultured for more than 
9 months without changing their doubling time (approximately 24 h) or their 
diameter (< 20 μm) while control cells became senescent during the same 
period. Even a single cell expanded to confluence in 100 mm dishes.  
Furthermore, to KO the CMAH gene, designed plasmids encoding a 
TALENs pairs were transfected into the immortalized cells. Each single 
colony was analyzed by the mutation sensitive T7E1 assay, fPCR and 
sequencing to obtain 3 independent clonal populations of cells that 
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contained biallelic modifications. The GGTA1 gene KO processes was 
exactly same with that of CMAH KO cell line establishment method. One 
hTERT overexpressed plus CMAH KO clone was chosen and used for 
SCNT. Cloned embryos developed to the blastocyst stage. 
To produce target gene overexpressed and knocked out pigs, PD related 
genes were selected; SNCA and PRKN. 
Here, I produced 23 cloned pigs expressing human SNCA via SCNT. 
Among them, 4 pigs survived (designated PDF4, PDF16, PDF18 and 
PDF20) and were confirmed as transgenic animals by PCR based analysis. 
Target proteins were detected in only 2 transgenic pigs (PDF4 and PDF18) 
by ELISA at 4 months of age. However, SNCA concentrations in blood 
samples were changed at 1 year of age. PDF4 and PDF20 showed 
significantly increased levels of SNCA. The SNCA concentration in PDF18 
significantly decreased, while that of PDF16 did not change during 1 year 
after birth. Behavior scoring analysis was carried out in control pigs and all 
cloned pigs at timed intervals (Control, unchanged; PDF18, decreased; 
PDF4, PDF16 and PDF20, increased; PD like behavioral changes lead score 
increasing). Similar changes were detected in both ELISA and behavior 
scoring analyses at timed intervals. 
PRKN gene was chosen for KO pig production. PRKN specific TALEN 
pairs were transfected in to pig somatic cells with reporter, 2 to 3 days after 
transfection GFP signal released cells were chosen for SCNT without 
i v  
 
specific selection processes. Eight cloned piglets were born and named, 
PDM1 to 8. In three (PDM3; heterozygote, PDM5; homozygote, PDM6; 
homozygote) out of eight, PRKN mutation was confirmed. However, these 
three KO piglets were dead (PDM3; unknown reason, PDM5; euthanasia 
because of cleft, PDM6; stillbirth). Nevertheless cell lines from those KO 
pigs except PDM6 were established and will be employed for re-cloned KO 
piglets.  
In conclusion, I demonstrated that immortalized porcine fibroblasts were 
successfully established using the human hTERT gene and the TALEN pairs 
enabled gene disruptions in these immortalized cells in vitro. Additionally, 
these transfected cells also develop into the blastocyst stages via SCNT. 
Based on these in vitro studies, SNCA overexpressed pigs and PRKN KO 
pigs were successfully produced. Furthermore protein analysis, behavioral 
changes, and brain imaging analysis were scheduled in both SNCA 
overexpressed pigs and PRKN KO pigs those were planned to reproduce. 
Key words: Transgenic animal, SCNT, gene overexpression, gene KO 
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Hypothesis and Purpose 
 
In this thesis, I hypothesized that several well-developed transgenic 
techniques in mice (e.g., overexpression by random insertion or KO by 
TALEN transfection) could also be applicable to establish porcine 
transgenic cell lines. Moreover, feasibility of transgenic piglet production 
via the same techniques was proved. For this hypothesis, three aims as 
below were investigated in my thesis.  
First, in Chapter I of PART III., to investigate overexpression and KO in 
porcine cells. hTERT genes were randomly inserted in cultured porcine cells. 
After confirmation of immortalization characteristics of transfected cell 
lines, two candidate genes, CMAH and GGTA1, were to choose for KO sites. 
Embryonic development of those immortalized and KO cells were to 
evaluate for further use of those cells as SCNT donors.  
Second, in Chapter I of PART IV., to produce PD model pigs, SNCA was 
to randomly insert into normal porcine cells then, conduct the SCNT with 
the transfected cells. The potentials of produced piglets as PD model would 
be evaluated by protein and behavioral analyses. 
Lastly, in Chapter II of PART IV., to evaluate the feasibility of KO via 
TALEN for PD model, PRKN KO cells with specific TALEN pairs were to 













1. Genome engineering 
Engineered nucleases recognize the target locus and induce DSB in 
genomic DNA (Bitinaite et al., 1998; Christian et al., 2010; Marraffini and 
Sontheimer, 2010). DSB is one of a disaster for cell, without fast recovery 
damaged cell goes to apoptosis. DSB repair machineries in cells recover the 
integrity of the genome by two major repair pathway, those names are 
NHEJ and HR in eukaryotic cells. 
NHEJ is a fast, simple, efficient repair pathway with error prone. DNAs 
were repaired without any complementary sequences in this repair process. 
Several fragments of DNA were inserted or deleted by chance. Normally, 
this causes frame shifted from damaged sites, and then truncated none 
functional protein is translated. This is called loss of function mutation. 
HR is error free repair machinery, because damaged DNA is copied from 
homologous fragment of DNA, which is artificially inserted or naturally 
existed (e.g., sister chromatid). Homologous sequences flanked expected 
genes are exactly introduced to the damaged site of genome, which causes 







 ZFN is artificially constructed restriction enzyme, made by conjugation of 
DNA binding domain of zinc finger protein and Fok1 endonucleases (Kim 
et al., 1996). The DNA binding domain of zinc finger can be modified to 
target expected DNA sequences. Thus zinc fingers detect desired site of 




 TALEN is made by fusion of TAL effector DNA binding protein and Fok1 
endonuclease. TAL effector DNA binding sites are modified easily to bind 
exact site of genome. Then Fok1 endonuclease can induce DSB in any 
desired location of genomic DNA (Figure 1B) (Christian et al., 2010).  
 
2.3. RGEN 
 This novel gene editing tools were developed from bacteria adaptive 
immune machinery. The Cas9 protein forms a sequence specific 
endonuclease with two RNAs (one for guide target site; named as crRNA, 
another for combine crRNA to Cas9 protein, named as tracrRNA) (Pennisi, 
2013). Unlike other genome engineering tools (ZFN and TALEN), RGEN 
has minimal restriction. This RGEN normally recognize 23 bps in length 
and ends with two guanines (GG). However theoretically, GG sequences 
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appear every 8 bps in genome that makes this no more limitation for 
selection target sequences. Moreover, non-ambiguous interactions between 
crRNA and target DNA sequences, which is expected to provide high 






Figure 1. Representative images for genome engineering. (A) Zinc finger 
nuclease (ZFN). (B) Transcription activator-like effector nuclease (TALEN). 




2. SCNT  
 
Briggs and King cloned tadpoles (Briggs and King, 1952). They used 
blastomeres from 8-16 thousands embryos as a donor cells for SCNT. They 
produced 27 tadpoles from 104 SCNT trials, but those few surviving 
tadpoles were abnormal. So they thought that cloned animals from fully 
differentiated cells are impossible. However lots of scientist noticed the 
possibilities of animal cloning. Ten years later, Gurdon finally produced 
cloned frogs (Gurdon, 1962).  
The first mammal Dolly, the sheep, was cloned from fully differentiated 
adult mammary cell in 1996 by Wilmut (Campbell et al., 1996), lots of 
mammals including, mouse (Wakayama et al., 1998), cattle (Cibelli et al., 
1998), goat (Baguisi et al., 1999), pig (Polejaeva et al., 2000), gaur (Lanza 
et al., 2000), mouflon (Loi et al., 2001), cat (Shin et al., 2002), rabbit 
(Chesne et al., 2002), mule (Woods et al., 2003), rat (Zhou et al., 2003), 
horse (Galli et al., 2003), dog (Lee et al., 2005a), ferret (Li et al., 2006), and 
wolf (Kim et al., 2007) are produced by SCNT (Table 1).  
SCNT is well developed laboratory technique for creating cloned embryos, 
which can be applied in therapeutic, pharmaceutic, conservative and 
transgenic cloning. Briefly introducing SCNT, fully differentiated cells were 
injected into the perivitelline spaces of enucleated matured oocytes. 
Followed by the nucleus of somatic cells are reprogrammed by the 
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cytoplasm of oocytes. Reconstructed embryos then transferred into the 
uterus of recipients.  
In therapeutic cloning, patient derived somatic cells are introduced into the 
oocytes. SCNT derived embryos are dissected and cultured under 
appropriate culture conditions, and then ESCs or cells derived from embryos 
can be used for therapeutic purpose. SCNT derived embryos can provide 
cells which are almost same characteristics of patients.  
In conservative cloning, SCNT can be used for rescuing some endangered 
or already extinct animals. In previous studies, endangered wolves were 
cloned by using SCNT (Kim et al., 2007). Also cells from post mortem 
wolves could be used as donor cells for SCNT (Oh et al., 2008). 
Furthermore frozen cells were used for SCNT, and healthy mice were 
produced (Wakayama et al., 2008). Resurrection of extinct animals (e.g., 
mammoths) might be possible in close future. 
In pharmaceutical cloning, lots of valuable substances, such as; human 
factor VIII (Paleyanda et al., 1997), hemoglobin (Swanson et al., 1992), and 
von Willebrand factor (Lee et al., 2009) could be obtained from transgenic 
animals via SCNT. 
Lastly, in transgenic cloning, SCNT has lots of advantages. First of all, 
SCNT reduce time and costs for making transgenic animals. When using 
strictly confirmed transgenic donor cells, all pups are transgenic animals. At 
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least one breeding process is needed if using another method (e.g., 
blastocyst microinjection) for producing transgenic animals.  
Especially in livestock, SCNT is the best choice technique to produce 





Table 1. Lists of animals that have been firstly cloned 
Species Years Donor cell types References 
Sheep 1996 Adult mammary epithelial (Wilmut et al., 1997) 
Cattle 1998 Fetal fibroblast (Cibelli et al., 1998) 
 1998 Adult oviduct epithelial (Kato et al., 1998) 
Mouse 1998 Adult cumulus (Wakayama et al., 1998) 
 1999 Embryonic stem cell (Wakayama et al., 1999) 
Goat 1999 Fetal fibroblast (Baguisi et al., 1999) 
Pig 2000 Adult cumulus (Polejaeva et al., 2000) 
Gaur 2000 Adult fibroblast (Lanza et al., 2000) 
Mouflon 2001 Adult granulosa (Loi et al., 2001) 
Cat 2002 Adult cumulus (Shin et al., 2002) 
Rabbit 2002 Adult cumulus (Chesne et al., 2002) 
Rat 2003 Fetal fibroblast (Zhou et al., 2003) 
Mule 2003 Fetal fibroblast (Woods et al., 2003) 
Horse 2003 Adult fibroblast (Galli et al., 2003) 
Dog 2005 Adult fibroblast (Lee et al., 2005a) 
Ferret 2006 Adult cumulus (Li et al., 2006) 





3. Transgenic cloned pigs 
 
Pigs are not only considered important livestock but also necessary animal 
models in biomedical research (Matsunari and Nagashima, 2009). Velocity 
of transgenic mice production and gene modification technologies is 
untraceable. However differences between humans and mice prevent from 
utilizing the data those were obtained from mice experiments into 
therapeutic realm directly. In contrast, pigs have many anatomical and 
physiological similarities to those of humans. Their physiological sizes of 
organs are also similar with human organs (Matsunari and Nagashima, 
2009). Additionally pigs have another good reasons for research area; 1. 
Less ethical problems were emerged when it compared to other animals 
because of industrial animals. 2. Multipara characteristic is fit for large 
reproducibility in industrial areas. 3. Base facilities are already well 
established. Of those reasons, pigs are promising animals in transgenic 
animal production research areas. 
After the first cloned pig was reported (Polejaeva et al., 2000), 
considerable research have been accomplished to produce disease model 
transgenic, reporter gene transfected, and xeno-transplantation model 
transgenic pigs.  
First, in case of disease model transgenic pigs, porcine retinitis pigmentosa 
disease models were established (Petters et al., 1997), Huntington disease 
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model (Uchida et al., 2001), cardiovascular disease model (Lai et al., 2006), 
cystic fibrosis model (Rogers et al., 2008b; Rogers et al., 2008a), and 
Alzheimer’s disease animal model (Kragh et al., 2009)were also produced. 
Other disease model was diabetes mellitus model which was characterized 
by high blood glucose levels and complications, such as; diabetic 
retinopathy, nephropathy and neuropathy (Wild et al., 2004). Transgenic 
cloned pigs carrying a mutant human hepatocyte nuclear factor (HNF)-1α 
were created (Umeyama et al., 2009).  
Second, reporter gene inserted transgenic pigs were also largely reported. 
These pigs are highly useful in research that requires tracking of 
transplanted cells or tissues (Matsunari and Nagashima, 2009). eGFP 
inserted transgenic pigs were produced by many researchers (Park et al., 
2001; Kurome et al., 2006; Lai et al., 2002b; Hofmann et al., 2003; Hyun et 
al., 2003; Whitelaw et al., 2004; Lee et al., 2005b; Naruse et al., 2005; 
Webster et al., 2005; Yong et al., 2006; Brunetti et al., 2008). eGFP, eRFP, 
and eBFP inserted transgenic pigs were also established in 2005 (Webster et 
al., 2005). Finally, due to cytotoxicity of the RFP, huKO gene was newly 
developed from coral stone Fungia concinna (Matsunari et al., 2008).  
Third, bioreactor pigs were also developed for pharmaceutical reasons. 
Human factor VIII producing pigs (Paleyanda et al., 1997), hemoglobin 
producing pigs (Swanson et al., 1992), and von Willebrand factor secreting 
pigs were established by Lee et al., in 2009. 
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Finally, pigs can be used as xenotransplantation models due to shortage of 
organs for human patients. In order to accomplish successful organ graft 
pigs to humans, organ rejection should be solved. To overcome rejection, 
multiple gene modification is necessary. Representatively, GGTA1 gene KO 
pigs were produced (Lai et al., 2002a). This gene was thought that major 
factor of hyperacute rejection. Based on this, other genes were rapidly 
modified in transgenic pig research (Takahagi et al., 2005; Le Bas-
Bernardet et al., 2011; Mohiuddin et al., 2011). Production of multi gene 
modified pigs is time consuming, due to longevity to reach puberty and of 
reproductive cycle. SCNT could solve these limitations. Obtaining 
transgenic cells from fetuses or neonates, then repeated transfection to those 
harvested cells could be possible. Using those transfected cells for donors to 
SCNT could improve the speed of multi gene modified pig generations. 
Also, developed gene handling techniques such as; 1. Polycystronic gene 
regulation by 2A system, 2. RMCE based exact target gene modulation, 3. 
Transposable elements to improving genes insertion into genomic DNAs, 4. 
Small hairpin RNAs to knock down target genes, and 5. Gene editing tools 
(ZFN, TALEN, or RGEN) to KO target genes are combined very fast during 
recent years (Table 2).  
 In table 2, newly emerging technologies were introduced in pig 
production area with speed. Proportions of gene editing tools to produce 
cloned pigs are greatly increased from 2013. Interestingly, among much 
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changes in methods to use pig production criteria, transposable elements 




















Chapter I. Experimental protocols for porcine cloning 
 
1. Chemicals and materials 
All chemicals were obtained from Sigma-Aldrich Co. LLC. (Missouri, USA) 
unless otherwise stated.  
 
2. Oocyte preparation 
 Pig ovaries were collected from a local abattoir (Wooseok food Inc., 
Kyeonggido, Korea) and transported to the laboratory within 3 h in 
physiological saline. Follicular fluid was aspirated from follicles 3 to 6 mm 
in diameter using an 18-gauge needle attached to a 10 ml syringe (Hwajin 
Ltd., Chungnam, Korea), transferred to 50 ml conical tubes (Catalog 
number; 50050, SPL Lifesciences, Kyeonggido, Korea), and incubated at 
39°C. After 15 min of sedimentation, the supernatant was discarded. The 
sediments were transferred to a 100 mm Petri dish (Catalog number; 10090, 
SPL Lifesciences) and washed with physiological saline containing 1% (v/v) 
P/S or porcine washing media (Table 3). COCs with intact, unexpanded 
cumulus cell layers and homogeneous cytoplasm were selected for further 
culturing. The COCs were cultured with IVM medium (Table 4) at 39°C 
under 5% CO2 in air for 22 h with 0.5 μg/ml of FSH and 0.5 μg/ml of LH. 
Next, the COCs were washed with Medium 199, transferred to hormone free 
IVM medium, and cultured at 39°C under 5% CO2 and 5% O2 in air for 
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another 22 h for final oocyte maturation. Cumulus cells were removed from 
the oocytes by repeated pipetting in Tyrode lactose (TL) medium 
supplemented with 10 mM HEPES and 0.3% (w/v) PVP (HEPES-TL-PVP) 
medium with 1 mg/ml hyaluronidase (This is the full name of TALP.). 
 
3. Donor cell preparation 
Pig fibroblast or kidney cells, which were used as control cells, were 
isolated and cultured. Tissues were washed 3 times in PBS and then 
chopped into small pieces in a 60 mm dish with trypsin. Trypsinized tissues 
were then incubated for 30 min at 37oC. Well dissociated tissues were 
centrifuged at 1,500 rpm for 2 min. The supernatant was discarded and the 
pellet was resuspended with PBS then centrifuged at 1,500 rpm for 2 min. 
These procedures were repeated 2 times. Finally, the supernatant was 
discarded and the pellet was resuspended in DMEM (Gibco, California, 
USA) supplemented with 20% FBS (Gibco), 1% P/S (Gibco), 1% NEAA 
(Gibco) and 100 mM β-ME by inverting the tube several times. The cells 
resuspended in this medium were held at room temperature (around 25oC) 
for 5 min, and then the suspension was transferred into a cell culture dish for 
approximately 10 days with culture medium changes every 2-3 days. These 
primary cells were cultured, expanded and frozen at -196oC for further use. 
The cell cultures were maintained in DMEM with 20% FBS, 1% P/S, 1% 




4. SCNT  
After 40 h of in vitro matured cumulus oocyte complexes (COCs) were 
move to 0.1% (v/v) hyaluronidase in TALP (Table 5) media. The cumulus 
cells were removed from oocytes by pipetting. Only denuded oocytes with 
homozygous cytoplasm were stained with 5 μg/ml bisbenzimide (Hoechst 
33342) for 10 min. Before starting enucleation process, well stained oocytes 
were moved to TALP for washing.  
For enucleation, the stained oocytes were transferred to 5 mg/ml 
cytochalasin B containing TALP media for enucleation. Observe the 
oocytes under the inverted microscope equipped with epifluorescence. 
Oocyte was held with a holding micropipette and the zona pellucida (ZP) 
was punctuated with an aspiration pipette to approach the polar body and 
nucleus of cytoplasm with a micromanipulator (Nikon-Narishige, Tokyo, 
Japan). The first polar body and adjacent cytoplasm containing the 
metaphase II chromosomes were enucleated by aspiration pipette.  
During injection step, prepared donor cells were suspended in TALP, and 
enucleated oocytes were also transferred to another TALP media without 
cytochalasin B. By using a same aspiration pipette, a cell with smooth 
cellular membrane was injected into the perivitelline space of an enucleated 
oocyte. The pore that was made in enucleation step was preferred to 
injection site.  
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At the fusion step, the couplets were serially equilibrated with fusion 
solution (Table 7) for several min and fused in 20 μl fusion solution droplet 
by applying an AC field of 5 V for 2 sec, followed by a DC pulses of 35 V 
for 2 sec, and frequency of 1 MHz for 30 µsec one pulse with 0.1 sec 
intervals using an electrical pulsing machine (LF101 Electro Cell Fusion 
Generator; NepaGene, Chiba, Japan).  
Activation step was followed within 30 to 60 min after fusion, fused 
oocytes were serially equilibrated with activation solution (Table 8) for 
several min and transferred to a chamber containing two electrodes overlaid 
with activation solution and activated with a single DC pulse of 1.5 kV/cm 
for 60 μsec using a BTX Electro-Cell Manipulator 2001 (BTX Inc., 
California, USA).  
Last, post-activation step, fully activated embryos were immediately 
transferred into PZM-3 (Table 6) or PZM-5 supplemented with 5 μg/ml 
cytochalasin B for 4 h for post-activation. The activated embryos were 
washed three times with PZM and transferred into the fresh PZM media 
under mineral oil, and then cultured at 39°C in a humidified atmosphere of 5% 




Table 3. Components of porcine oocyte washing media 
Component Catalog No. M.W.**** mM 
Medium 199 powder*   1 pack/l 
NaOH S8045 40.00 2 tablets/l 
NaHCO3 S5761 84.01 2 
HEPES H6147 238.31 10 
PVA** P8136  0.30% 
P/S***   1% 
*Medium 199 powder (Invitrogen; 31100-035, California, USA) 
**Polyvinyl alcohol 






Table 4. Components of porcine IVM media 
Component Catalog No. M.W.***** mM 
Medium 199 liquid*   500 ml 
NaHCO3 S5761 84.01 26.2 
Glucose G7021 180.16 3.05 
Na pyruvate P4562 110.04 0.91 
Ca lactate L4388 103.1 2.92 
L-cystein C7477 157.62 0.57 
Kanamycin K1377 582.58 0.075 
PFF**   10% (v/v) 
FSH***   0.5 μg/ml 
LH****   0.5 μg/ml 
*Medium 199 liquid (Invitrogen; 11150-059, California, USA) 
**Porcine follicular fluid 







Table 5. Components of TALP 
Component Catalog No. M.W.*** mM 
NaCl S5886 58.44 114 
KCl P5405 74.55 3.1 
CaCl2 ㆍ 2H20 C7902 147.02 2.1 
MgCl2ㆍ 6H20 M2393 203.31 0.4 
NaH2PO4ㆍ H20 S3522 138 0.3 
NaHCO3 S5761 84.01 2 
Na pyruvate P4562 110.04 0.2 
Glucose G7021 180.16 5 
HEPES H6147 238.31 10 
Kanamycin K1377 582.58 0.17 
PVP* P0930 40.00 0.30% 
BSA** A6003  3 mg/ml 
Na lactate L7900 112.06 10 
*Polyvinyl pyrrolidone 






Table 6. Components of PZM-3 
Component Catalog No. M.W.**** mM 
NaCl S5886 58.44 108.00 
KCl P5405 74.55 10.00 
KH2PO4 P5379 136.09 0.35 
MgSO4ㆍ 7H20 M7774 246.5 0.40 
NaHCO3 S5761 84.01 25.07 
Na-Pyruvate P4562 110.04 0.20 
Ca-Lactate L4388 103.1 2.00 
L-glutamine G8540 146.15 1.00 
Hypotaurine H1384 109.1 5.00 
BME amino acid* B6766  20 ml/l 
MEM NEAA** M7145  10 ml/l 
Kanamycin K1377 582.58 75 mg/l 
BSA*** A6003  3 mg/ml 
*Basal medium eagle amino acids 
**Minimum essential medium non-essential amino acid 






Table 7. Components of embryo fusion media 
Component Catalog No. M.W.** mM 
Mannitol M1902 182.17 280 
MgSO4 M2643 120.4 0.1 
PVA* P8136 238.31 0.01% (w/v) 
HEPES H6147 238.3 0.5 






Table 8. Components of embryo activation media 
Component Catalog No. M.W.** mM 
Mannitol M1902 182.17 280 
MgSO4 M2643 120.4 0.15 
PVA* P8136 238.31 0.01% (w/v) 
HEPES H6147 238.3 0.5 







5. ET and pregnancy test 
The surrogate mother was restrained and preanesthesia was induced by 
injection of ketamine (10 mg/kg; Yuhan, Seoul, Korea) and xylazine (1 
mg/kg; Bayer, Leverkusen, Germany) into an ear vein as previously 
described (Trim and Gilroy, 1985). The anesthetized pig was placed on a 
surgery table in a ventrodorsal posture. General anesthesia was maintained 
with isoflurane by concentration of 2.0 MAC (Hana Pharm, Seoul, Korea) 
under the supervision of a veterinarian.  
The recipient was ventrodorsally laid on surgical table, and uterus and 
ovaries were taken out from abdomen through midline incision. 
Reconstructed embryos were loaded into a Tomcat catheter (Catalog 
number; 8890703021, Covidien, Dublin, Ireland) with TALP medium 
equilibrated in 5% CO2 with air. Only 2- or 4-cell stage embryos were 
transferred into surrogate mothers those were 2 to 3 days after ovulation. 
The embryos were placed into the oviducts of each surrogate animal through 
a small puncture made with a suture needle (Catalog number; 6307-71, 
Covidien). The empty tomcat catheter was removed carefully, and then put 






6. Analysis of cloned animals 
6.1. PCR and RT-PCR 
For PCR analysis, genomic DNA was extracted with the G-spin Genomic 
DNA Extraction Kit (iNtRON Biotechnology, Gyeonggido, Korea) 
according to the manufacturer’s protocol. Amplification of target genes was 
achieved using Maxime PCR PreMix (i-StarTaq; iNtRON).  
For RT-PCR, total RNAs were extracted to analyze gene expression in the 
immortalized cells by using the easy-spin Total RNA Extraction Kit 
(iNtRON). Then, cDNAs were synthesized using Maxime RT Premix 
(iNtRON) according to the manufacturer’s protocol.  
 
6.2. Motor scoring analysis 
 The scoring analysis table for pigs was based on UPDRS (Mitchell et al., 
2000). This newly constructed scoring analysis table has 21 categories each 
with a score from 0 to 3, representing none to severe, respectively (Table 9). 




Table 9. Proposed motor scoring system for a porcine PD model based on 



















Chapter I. Production of CMAH KO preimplantation 
embryos derived from immortalized porcine cells 
via TALEN.  
 
1. Introduction 
Pigs are considered to be good biomedical models for topics such as 
xenotransplantation because of their many physiological similarities with 
humans (Matsunari and Nagashima, 2009; Lai et al., 2002a; Aigner et al., 
2010; Kwon et al., 2013). SCNT with genetically modified somatic cells has 
been used to generate pig models via transgenesis (Wolf et al., 2001). 
Typical gene modifications are ectopic expression or KO of target genes 
(Liu et al., 2013; Lutz et al., 2013). While many cloned piglets have been 
produced using ectopic expression, only three kinds of KO piglets (alpha-
galactosidase, cystic fibrosis and IL2 receptor) using HR have been born 
(Lai et al., 2002a; Rogers et al., 2008b; Rogers et al., 2008c). Developing 
KO pig models has been hampered to date because fibroblasts generally 
have a limited life span during IVC and because of the low efficiency of the 
HR process (Kwon et al., 2013). To overcome these two issues, 
immortalization of fibroblasts and more efficient KO protocols are needed. 
For immortalization, several genes such as BMI, SV40LT and hTERT can be 
transfected into cells. In previous studies, SV40LT and hTERT were used to 
immortalize porcine cells (Sagong et al., 2012; Saito et al., 2005; Oh et al., 
2007; Meng et al., 2010). 
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TALEN is an emerging high end technology used to create targeted double 
stranded breaks in DNA (Kim et al., 2013b). Currently, TALEN has been 
employed for genome editing, resulting in target gene deletion or insertion 
in human, mouse and rat cells (Kim et al., 2011; Zhu et al., 2013; Ding et al., 
2013; Tong et al., 2012; Panda et al., 2013). Application of TALEN to cells 
of large animals like pigs could more efficiently generate KO cell lines and 
thus help to elucidate the underlying molecular processes (Carlson et al., 
2012). After establishing KO cell lines, the cell nuclei could potentially be 
reprogrammed in enucleated oocytes and produce KO cloned offspring.  
In this study, to prove TALEN mediated KO, I elected to delete the 
CMAH gene, which is another important cell surface glycoprotein with 
alpha-galactosidase for xenotransplantation pig models and then gene KO 
cells were used for feasibility of embryonic development via SCNT. Here I 
hypothesized that using immortalization and TALEN approaches together in 




2. Materials and methods 
2.1. Primary cell culture and maintenance 
 Male fetal fibroblasts from one miniature pig fetus, which were used as 
control cells, were isolated and cultured. Euthanized fetus was dissected into 
3 parts: head, body and tail. Just the body parts of fetuses were washed 3 
times in PBS and then following the protocol previously established in our 
studies (Moon et al., 2014a). 
  
2.2. Immortalization 
For immortalization, hTERT (from Addgene, Plasmid #12245) were 
amplified by PCR. Purified hTERT fragments were inserted in pCMV-IRES-
DsRed vectors, which were purchased from Clontech (Seoul, Korea.). 
pCMV-hTERT-IRES-DsRed plasmids were transfected into male fetal 
fibroblasts which was same cells as control cells using FugeneHD (Figure 
2A). Two days after transfection, 1000 μg/ml, neomycin (G418; Gibco) 
were treated for 7 days to isolate the transfected cells and then growing cells 
to neomycin resistance were sub-cultured (Figure 2).  
 
2.3. Cell properties 
 2.3.1. Doubling time 
Controls and immortalized cells were plated in 12-well plates at 4×104 
cells/well. Every 24 h, cells in four of the wells were trypsinized and cell 
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numbers were calculated manually under a hemacytometer. Then, the 
doubling time was calculated using the doubling time online calculator 
(http://www.doubling-time.com/compute.php) every 3 passages up to 
passage 24 (Widera et al., 2009).  
  
2.3.2. Cell Size 
Images from trypsinized cells on the hemacytometer were taken under a 
microscope (×200). Sizes of one hundred cells were measured by ImageJ 
(http://rsbweb.nih.gov/ij/) every 3 passages up to passage 24 (Collins, 2007).  
 
 2.3.3. PCR  
Genomic DNA was extracted with the G-spin Genomic DNA Extraction 
Kit (iNtRON) according to the manufacturer’s protocol. Amplification of 
target genes was achieved using Maxime PCR PreMix (i-StarTaq; iNtRON). 
Primer sets, conditions and expected sizes are annotated in Table 10. 
  
 2.3.4. Sequencing 
Target DNA samples were delivered to a sequencing company (Macrogen 
Ltd., Seoul, Korea). Briefly, sequencing reactions were performed in the 
DNA Engine Tetrad 2 Peltier Thermal Cycler (BIO-RAD, California, USA) 
using the ABI BigDye (R) Terminator v3.1 Cycle Sequencing Kit (Applied 
Biosystems, California, USA), following the protocols supplied by the 
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manufacturer. Single pass sequencing was performed on each template 
using a selected primer (primer sequences: AACGTTCCGCAGAGAAAA 
GA). The fluorescent labeled fragments were purified by the method 
recommended by Applied Biosystems because it removes unincorporated 
terminators and dNTPs. The samples were subjected to electrophoresis in an 
ABI 3730xl DNA Analyzer (Applied Biosystems). 
 
 2.3.5. Karyotyping 
 To perform karyotyping, cultured cells were treated as follows. First, 200 
μl of colcemid (Gibco) stock solution was added to the culture. Then, the 
culture was returned to the incubator (37oC, 5% CO2) for 4 h. After 
incubation, cells were collected in 15 ml tubes and then centrifuged at 1000 
rpm for 10 min. The medium was carefully aspirated, then 5 ml of 
hypotonic solution (0.075 M KCl) was added and allowed to stand at 37oC 
for 10 min. Then, 500 μl of Carnoy’s fixative (Methanol: Acetic acid = 3:1) 
was added and mixed by inverting the tube, followed by centrifugation at 
1000 rpm for 10 min. The hypotonic solution was aspirated carefully and 3 
ml of Carnoy’s fixative was added and well mixed. After more than 20 min, 
the mixture was centrifuged at 1000 rpm for 10 min. The supernatant 
fixative solution was carefully aspirated till leaving about two times of 
volume to pellets. The pellet was spread on a prepared glass slide which was 
then baked at 60oC for 30 min. The slide was treated with 50% H2O2 for 3 
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min, and then baked again at 60oC for 30 min. Finally the slide was stained 
with the Giemsa stain-GTG banding method. Chromosome imaging were 
accomplished with the ChIPS-Karyo (Chromosome Image Processing 
System) (GenDix, Inc., Seoul, Korea). 
 
2.4. Single cell colony formation 
Trypsinized cells were placed on the lid of Falcon dish (Catalog number 
#351006; Falcon, New Jersey, USA) in drops of 20 μl of DMEM containing 
15% FBS, 1% P/S, 1% NEAA and 100 mM β-ME. To evaluate single cell 
colony forming competence, one cell was picked up in a micropipette 
attached to a micromanipulator. The cell was transferred into a 4 μl drop of 
DMEM containing 15% FBS, 1% P/S, 1% NEAA and 100 mM β-ME that 
was covered with mineral oil. After seven days, growing cell colonies were 
collected and sequentially sub-cultured into 96-, 24- and 6-well plates. Then, 
cells from the 6-well plates were moved sequentially to 60mm and 100mm 
dishes. 
 
2.5. Gene expression 
 Total RNAs were extracted to analyze gene expression in the immortalized 
cells by using the easy-spin Total RNA Extraction Kit (iNtRON). Then, 
cDNAs were synthesized using Maxime RT Premix (iNtRON) according to 
the manufacturer’s protocol. Information on primers is listed in Table 11. 
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Gene expression for p53, p16, Bax, Bcl-xl, DNMT1, DNMT3a, DNMT3b, 
GLUT1, and LDHA was measured with a real-time PCR machine (7300 
Real-Time PCR System; Applied Biosystems). 
 
2.6. Telomerase activity test 
 Quantification and characterization of telomerase activity was measured by 
the TRAP. For this test, TeloTAGGG Telomerase PCR ELISAPLUS (Roche, 
Basel, Switzerland) kit was used with manufacturer’s indications (Mariani et 
al., 2003). RTA within different samples in an experiment were obtained 
using the following formula;  
RTA = [(AS-AS0)/AS,IS]/[(ATS8-ATS8,0)/ATS3,IS]×100  
(AS; absorbance of sample, AS,0; absorbance of heat treated sample, AS,IS; 
absorbance of internal standard (IS) of the sample, ATS8; absorbance of 
control template, ATS8,0; absorbance of lysis buffer, ATS8,IS; absorbance 
of IS of the control template). 
 
2.7. SCNT 
Donor cells were subjected to SCNT, which was done following the 
protocol previously established in our studies (Koo et al., 2009). Briefly, 
immature oocytes were obtained from pig ovaries and cultured for 40 h to 
support maturation. The in vitro matured (IVM) oocytes were enucleated 
using an aspiration pipette, then microinjected with a control or transfected 
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donor cell, fused by electrical stimulation and activated using an electrical 
protocol. The resulting activated embryos were cultured for seven days. 
Cleavage and blastocyst stages were observed on Day 2 and 7 of culture, 
respectively. 
 
2.8. CMAH KO using TALE nucleases and magnetic separation 
1x106 immortalized cells were transfected using 30 μl of TurbofectTM 
(Fermentas Inc., Maryland, U.S.A.) and 10 μg of plasmid DNA at a weight 
ratio of 45:45:10 (plasmid encoding a TALEN: plasmid encoding the other 
TALEN: magnetic reporter) according to the manufacturer's protocol (Kim 
et al., 2011; Kim et al., 2013a). The transfected cells were cultured for two 
days at 37oC and subjected to magnetic separation. Trypsinized cell 
suspensions were mixed with magnetic bead conjugated antibody against H-
2Kk (MACSelect Kk microbeads; Miltenyi Biotech, Cologne, Germany) and 
incubated for 15 min at 4oC. Labeled cells were separated using a column 
(MACS LS column; Miltenyi Biotech) according to the manufacturer's 
protocol. 
 
2.9. T7E1 assay 
Genomic DNA was extracted using the G-DEX IIc Genomic DNA 
Extraction Kit (iNtRON) after 3 days of transfection. TALEN target sites 
were PCR amplified using primer pairs listed in Table 10. The T7E1 
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analysis was done as described previously (Kim et al., 2009). The amplicons 
were denatured by heating and annealed to form heteroduplex DNA, which 
was treated with 5 units of T7E1 (New England Biolabs, Massachusetts, 
USA) for 20 min at 37oC and then analyzed by 2.5% agarose gel 
electrophoresis. 
 
2.10. Fluorescent PCR 
Carboxyfluorescein (FAM) was labeled on 5’ of the forward primer by an 
oligo synthesis company (Bioneer Corporation, Daejon, South Korea). PCR 
products were processed for fragment separation by capillary 
electrophoresis on an ABI 3730xl using POP-7 polymer. The GeneScan 
Rox500 size standard (Life technologies, California, USA) was run as an 
internal size marker. Samples were denatured at 95oC for 5 min and run on 
the Genetic Analyzer. Data were analyzed for allele sizes and peak heights 
using the pick scanner software v1.0 (Life technologies).  
 
2.11. FACS  
CMAH biallelic KO cells were trypsinized and resuspended in staining 
buffer (0.1% BSA in PBS) to reach a final concentration of 5×105 to 1×106 
cells/ml. The cells were incubated for 20 min on ice with the antibody anti 
Neu5Gc (Sialix, Massachusetts, USA). After incubation, the cells were 
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washed twice with staining buffer and resuspended, and then the stained 
cells were analyzed by FACS. 
 
2.12. Statistical analysis 
 All data were analyzed by one way ANOVA followed by Tukey’s multiple 
comparison tests or paired t-test using GraphPad Prism version 5.01 to 
determine differences among experimental groups. Statistical significance 





3.1. Cell properties 
3.1.1. Differences between controls and immortalized cells in 
morphology, doubling times and cell size 
After transfection, outgrowing colonized fibroblasts were cultured. Along 
with immortalization of the cells, their size was reduced (Figure 2D). 
Mean doubling time of control and immortalized cells were 46.4±1.1 and 
26.9±0.6 h, respectively, and these values were significantly different (p < 
0.05) (Figure 2B). Mean cell size of the immortalized cells was 17.9±0.2 
µm and always less than 20 µm while mean cell size of control cells was 
progressively increasing until finally these cells entered into replicative 
senescence. Significant differences in cell size between control and 
immortalized cells were observed from passage 12 (Figure 2C). 
 
3.1.2. PCR, RT-PCR and Sequencing  
Integration and expression of the hTERT gene was observed by PCR and 
RT-PCR in 3 and 18 passages of control and immortalized cells, respectively. 
PCR and RT-PCR data indicated that the hTERT gene was integrated into 
immortalized cells (Figure 3A and 3B). Also, sequencing results from both 
PCR amplicons were exactly the same as those inserted sequences from the 





A total of 20 cells in each analysis were subjected on karyotyping. 
Karyotyping of immortalized cells, prior to passage number 15, revealed 
normal chromosomes while subsequently abnormal chromosomes were 
detected in one cells (Figure 2E). Similar observations were made in control 
cells, indicating that eight cells showed abnormalities (trisomy in 
chromosome #17) (Figure 2E). 
 
3.2. Single cell colony formation 
Immortalized cells could be populated from a single cell in a 100mm dish. 
This ability was replicated three times more using single cells. However, 
control cells did not have the ability to be expanded from a single cell in a 
100mm dish (Figure 6). 
 
3.3. Gene expression 
 Gene expression in immortalized cells and control cells are summarized in 
Figure 3D. In this analysis, tumor suppressor gene (p53) expression level 
was not significantly changed during increasing passage number in 
immortalized or control cells except passage 6 and 15. Cyclin-dependent 
kinase inhibitor 2A (p16) expression was significantly down regulated 
during increasing passages (from passage 6) in immortalized cells. Also Bax, 
which is a well-known proapoptotic gene, was significantly down regulated 
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during increasing passage numbers (from passage 6) in immortalized cells. 
However, Bcl-xl, an antiapoptotic gene, was significantly changed in 
passage numbers 6 and 18. In analysis of metabolic genes, expression of 
GLUT1 and LDHA were significantly up regulated in late passage of 
immortalized and control cells, respectively. Expression of methylation 
relation genes (DNMT1, DNMT3a and DNMT3b) was not changed (Figure 
7). 
 
3.4. Telomerase activity test 
 RTA of control and immortalized cells were 0.41 ± 0.16 and 5.37 ± 0.09, 
respectively. Telomerase activity was significantly increased in 
immortalized cells compared to control cells (Figure 5). 
 
3.5. Preimplantation development of cloned embryos derived from 
immortalized cells 
 Development rates were evaluated in three groups: parthenogenetic 
activated embryos (total numbers of oocytes: 211), SCNT derived embryos 
using control somatic cells as nuclear donors (total numbers of oocytes: 112) 
and SCNT derived embryos using immortalized cells as nuclear donors 
(total numbers of oocytes: 107). Three replicates were done in all three 
groups. Two days after activation, CRs evaluated under a microscope were 
81.6±2.2%, 68.1±0.8% and 71.8±3.6%, respectively. No significant 
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differences were observed in CR among the three groups. However, 
significant differences were observed in BRs, which were 32.3±1.2%, 
11.5±0.7% and 2.9±0.2%, respectively (Figure 3C). 
 
3.6. CMAH KO and SCNT 
After transfecting TALEN DNAs, 500 reporter gene positive cells were 
cultured in a 100 mm dish and grown into colonies; 116 single cell derived 
colonies were selected. In a T7E1 mutation assay, I found 45 colonies to be 
mutated (Figure 9). Among these 45 colonies, I subjected to fluorescent 
PCR for determination of biallelic mutated colonies (Figure 10). Three 
biallelic mutation colonies with morphologically good cells were finally 
selected and sequenced for confirmation of biallelic mutation (Figure 4D). 
In #13, 1 bp insertion and 1bp deletion were found, in # 24, a 282 bps 
insertion (sequence of 282 bps was noted in Figure 11) and in #26, 2 bps 
and 8 bps deletions were observed (Figure 4C). In addition, as shown by 
FACS, CMAH expression was removed in all three cell lines (Figure 4E). 
Furthermore, thirty six cloned embryos derived from CMAH KO cells were 
reprogrammed after insertion into enucleated oocytes, cleaved (91.7%) and 




Figure 2. Cellular analysis of porcine immortalized cells. (A) Illustration of 
pCMV-hTERT-IRES-DsRed, (B) Population doubling time, significant 
differences in doubling time between control and immortalized cell were 
investigated and those were 46.4±1.1 and 26.9±0.6, respectively. (C) Size 
differences between control cells and immortalized cells, mean cell size of 
the immortalized cells were 17.9±0.2 which was constantly under the 20 µm 
while that of control cells were sequentially increasing in mean cell size and 
finally these cells were enter into senescence or crisis. Significant 
differences in cell size between control and immortalized cells were 
observed from passage number 12. (D) Morphologies of control cells and 
immortalized cells, numbers represent passages. (E) Results of karyotyping, 
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both control and immortalized cells showed abnormalities from passage 





Figure 3. Gene expression in immortalized cells and embryonic 
development. (A) Detection of hTERT, (M; marker, +; positive control 
vector, -; negative control vector, c; control cells, i; immortalized cells and 
numbers referred to passages). (B) Expression of hTERT, (M; marker, +; 
positive control vector, -; negative control vector, c; control cells, i; 
immortalized cells and numbers referred to passages). (C) Early embryonic 
development, changes among early embryonic development when cells 
properties were changed into immortal states. Those control and immortal 
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indicated SCNT results when the donor cell were control and immortalized 
cells, respectively. CRs were not changed among groups, but BRs were 
serially significantly decreased among three groups. (D) Gene expression, 
tumor suppressor gene (p53) expression level was not significantly changed 
during the increasing of passage number in immortalized cells/control cells. 
Cyclin-dependent kinase inhibitor 2A (p16) expression were significantly 
down regulated during the increasing of passage numbers in immortalized 
cells/control cells. Also Bax, which is well known for proapoptotic gene, 
were significantly down regulated during the increasing of passage numbers 
in immortalized cells/control cells. However Bcl-xl, antiapoptotic gene, was 
significantly up regulated during the increasing of passage numbers in 





Figure 4. Generating CMAH KO cells and its analysis. (A) DNA-binding 
sequences and the spacer region for CMAH-TALEN. (B) T7E1 assays, 
T7E1 assays were conducted using genomic DNA from three CMAH KO 
clones. The arrow indicates the size (~170 bps) of T7E1 digested DNA 
fragments. (C) DNA sequences of the CMAH locus from each CHAH KO 
clone. ‘-’ denotes deleted nucleotides. Red colored upper case letter and 
lower case letter sequences represent nucleotide substitutions and insertion, 
respectively. (D) fPCR assay of the CMAH KO clones. (E) FACS analysis 
of CMAH KO clones. The expression level of Neu5Gc is detected by anti-
Neu5Gc antibody on the CMAH KO cell membrane. The expression levels 
of Neu5Gc on each CMAH KO clone are comparable with control (+). 
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Figure 5. RTA. RTA of control and immortalized cells were 0.41 ± 0.16 and 
5.37 ± 0.09, respectively. Telomerase activity was significantly increased in 
immortalized cells compared to control cells. 
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Table 10. List of primers 
Gene 
Primer sequences (5’-3’) Size of PCR 
product (bp) 
GenBank 
accession no. Forward Reverse 
hTERT GTGGTGAACTTCCCTGTAGAAGAC GAAACAGGCTGTGACACTTCAG 250 NC_000005.9 
GAPDH ACCTGCCGTCTGGAGAAACC GACCATGAGGTCCACCACCCTG 252 AF017079 
1st 
CMAH 
TTGGTCTTCAGCCCTCATCT CTGGTAGCAAGGGCAGTTTC 743 NM_001113015.1 
2nd 
CMAH 
TTGGTCTTCAGCCCTCATCT ATTTAACATTTCCTTACCTGCAC 307 NM_001113015.1 
fPCR 
CMAH 





Table 11. List of real-time PCR primers 
Gene 
Primer sequences (5’-3’) Size of PCR 
product (bp) 
GenBank 
accession no. Forward Reverse 
Bcl-xl TGGTGGTTGACTTTCTCTCC ATTGATGGCACTAGGGGTTT 134 AF216205 









































Figure 6. Single cell culture of immortalized cell. Single cell in 4 μl drop of 
culture media were observed by under left listed time. Only one cell was 
plated on the cell culture dish (0 h), after 24 h that cell attached onto the 
dish. Attached cell divided continuously with time to establish the one 





Figure 7. Comparison of methylation and metabolism related gene 
expression between control and immortalized cells. Methylation related 
DNMT1, DNMT3a, and DNMT3b genes were evaluated. No significant 
differences were observed in methylation patterns of control cell lines 
between immortalized cell lines at any passages. However, in analysis of 
metabolic genes, expression of GLUT1 and LDHA were significantly up 






Figure 8. Sequencing results from genomic DNA from immortalized cell 






Figure 9. T7E1 assay results from CMAH KO single cell colonies. CMAH 
KO single cell colonies were subjected on T7E1 assay for confirming 
knocked out colonies. Among 116 colonies, 45 colonies were knocked out, 





Figure 10. fPCR results from CMAH KO single cell colonies. Five colonies 
were confirmed that biallelic KO colonies with fPCR results (#13; 1bp 
deletion (del), 1bp insertion (ins), #24; 282bp ins/8bp del, 282bp ins/8bp del, 
#26; 8bp del, 2bp del, #36; 24bp del, 25bp del, and #38; 18bp del, 19bp del). 
Among them 3 colonies were strictly confirmed that biallelic KO colonies 
with fPCR and sequencing those were #13, #24 and #26 (red colored letter). 
Colony number 31 and 114 (yellow colored letter) were contaminated 












Figure 11. Inserted 282 bps sequence in #24 colony. Huge gene insertion 






Figure 12. SCNT with CMAH KO donor cells. (A) A blastocyst derived 
from SCNT with CMAH KO donor cell. CMAH KO cells were employed 
into enucleated oocytes for determination of developmental competence. (B) 
Development rates were evaluated in two groups: parthenogenetic activated 
embryos (total numbers of oocytes: 69) and SCNT derived embryos using 
CMAH KO cells as nuclear donors (total numbers of oocytes: 36). Only one 
replicates were done in all two groups. CRs were 81.2% and 91.7%, 
respectively and BRs were 33.3% and 2.8%, respectively. (PA; 
parthenogenetic activation, KO; knockout, CR; cleavage rate, BR; 





Figure 13. Illustration of TALEN binding sites and results of GGTA1 
TALEN KO. (A) DNA binding sequences and the spacer region for GGTA1 
TALEN. (B) T7E1 assays. (C) DNA sequences of the GGTA1 locus from 
each GGTA1 KO clones. (D) fPCR assay of the GGTA1 KO clones. (E) 





Figure 14. T7E1 assay results from 1st GGTA1 KO single cell colonies. 
GGTA1 KO single cell colonies were subjected on T7E1 assay for 
confirming knocked out colonies. Among 57 colonies, 27 colonies were 






Figure 15. fPCR results from 1st GGTA1 KO single cell colonies. Three 
colonies were confirmed that biallelic KO colonies with fPCR results (#1-9; 
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4bp del, 2bp del, #1-13; 2bp ins, 22bp ins, #1-17; 25bp del, 18bp del; red 
colored letter). Colony number 1-7, 1-14, 1-19, and 1-21 (yellow colored 
letter) were contaminated colonies. Other colonies (black colored letter) 





Figure 16. T7E1 assay results from 2nd GGTA1 KO single cell colonies. 
GGTA1 KO single cell colonies were subjected on T7E1 assay for 
confirming knocked out colonies. Among 66 colonies, 26 colonies were 




Figure 17. fPCR results from 2nd GGTA1 KO single cell colonies. Two 
colonies were confirmed that biallelic KO colonies with fPCR results (#2-31; 
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3bp del, 53bp del, #2-62; 72bp del, 72bp del; red colored letter). Colony 
number 2-3, 2-4, 2-5, 2-6, 2-12, 2-14, 2-15, 2-26, and 2-60  were 





It is well established in humans and in mice that cell lines are necessary to 
understand or to evaluate the molecular process (Todaro and Green, 1963; 
Graham et al., 1977; Scherer et al., 1953). However, in the pig, such 
research has been limited to date. In this study, I developed immortalized 
cells and furthermore those cells were used for TALEN to KO the 
interesting genes. 
 For inducing immortalization, genes such as SV40 large T antigen, mBMI 
and hTERT were used in previous studies (Garcia-Escudero et al., 2010). 
Among these genes, hTERT has especially been used to immortalize cells 
because of reduced chromosome damage (Ray et al., 1990; Garcia-Escudero 
et al., 2010). In this study, hTERT successfully induced pig fetal fibroblasts 
into immortalization. In addition, our immortalized cells can be cultured for 
single cell colony formation at least three times. Therefore, single 
immortalized cell was cultured and propagated to unlimited numbers, 
indicating that single mutated cells can be isolated and used for many assays 
requiring cells, DNAs, RNAs and proteins. 
For investigating properties of the immortalized cells, expression of 
proliferative, apoptotic, metabolic and methylation related genes were 
analyzed. Even though significant change of p53 expression at specific 
passage was observed during long term culture, p16 was dramatically down 
regulated (Figure 3D) from passage 6. The fact that loss of p16 function 
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after transfection with hTERT is much related to immortalization is on the 
same line with our results (Kim et al., 2002). As expected, antiapoptotic 
gene (Bax) was increased but proapoptotic gene (Bcl-xl) was decreased. In 
metabolic gene expression, GLUT1 was significantly increased because 
immortalized cell utilize much more glucose for unlimited cell proliferative 
competence like cancer cell (Macheda et al., 2005). And expression of 
LDHA, which is soluble cytosolic enzyme resulting from apoptosis or 
necrosis was increased in late passage control cells (Chan et al., 2013). One 
point is about methylation gene expression. In contrast to our results, a 
previous study reported increase of DNMT1 expression in human fibroblast 
after hTERT transfection (Young et al., 2003). However, in our case, the 
DNMTs expression levels were not changed after immortalization. In this 
study, I found that down regulation (p16 and Bax) and up regulation 
(GLUT1 and telomerase activity) plays an important role in maintaining the 
unlimited cell propagation (Figure 3D, Figure 5, and Figure 7). 
Additionally, it has raised a scientific interest on SCNT embryo production 
using immortalized cells with long term culture properties. With respect to 
early embryonic development, no significant differences were observed in 
CRs among PA embryos, SCNT embryos derived with control cells and 
SCNT embryos derived with immortalized cells. However, significant 
differences were observed in BRs among these three groups. In particular, 
BRs were significantly decreased in the immortalized cell SCNT group. The 
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very low embryonic development using immortalized cells is similar to that 
reported in a previous study, in which immortalized bovine epithelial cells 
used in SCNT could not support embryo development into blastocysts 
(Zakhartchenko et al., 1999). However, with ovine immortalized fibroblasts 
using hTERT as in this study, there was no significant difference between 
control and immortalized groups in their ability to support SCNT early 
embryo development (Cui et al., 2003). In two previous studies, (Cui et al., 
2003; Zakhartchenko et al., 1999), it was concluded that transformed cells 
with abnormal cellular responses (like serum starvation) failed to support 
embryonic development into blastocysts. Therefore, I assume that 
morphological and proliferative changes in our cells immortalized using 
hTERT affected normal cellular gene expression profiles including p16 and 
resulted in very low embryonic development. This is another possible 
reason why SCNT embryos using immortalized cells could not well 
developed to blastocysts. 
TALEN, an emerging genome editing tool can be applied to generate 
mutant pigs. To KO a gene using TALEN, several pairs on a specific coding 
domain region should be designed and evaluated for choosing the most 
effective pairs. Thus, effective TALEN DNA pairs deleted the DNA with an 
efficiency of 3.9% - 43% to date (Kim et al., 2013b). However, validation 
systems to determine effective pairs in different species could provide 
different genome editing efficiencies (Yang et al., 2011). In fibroblasts, 
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before homogeneous KO cell lines were achieved, single isolated mutated 
cells became senescent and thus could not be subjected to further analysis 
and application. Therefore, I strongly suggest that in porcine genome editing, 
these immortalized cells could be used as appropriate in vitro test cell lines 
to select effective pairs of TALEN. 
Because in this study our immortalized cell line can be grown up from a 
single cell into billions of cells, I randomly chose one hundred single cells 
and cultured them into colonies of homogeneous s cells. Using single cell 
colony formation competence as a selection criterion, I can more easily 
generate KO cell lines. Indeed, in this study, single cell colonies grew well 
and these were used to analyze each colony to evaluate mutation 
characteristics. As a result, TALEN activity showed 38.8% efficiency and 
many cell lines were isolated (Figure 9). From the finally chosen cells, three 
biallelic mutated cell lines developed that did not express the cell surface 
carbohydrate chain, Neu5Gc. From one of these three mutated cell lines, 
colony number 24, cells were used as nuclear donor cells for SCNT. 
Although the BR was low, I observed that immortalized cells with CMAH 
KO can be reprogrammed in porcine enucleated oocytes and develop to the 
blastocyst stage. Additionally, the other gene, GGTA1, which is responsible 
for hyperacute rejection in xenotransplantation, was also knocked out in this 
cell line using exactly the same methods with high efficiency (Figure 13-17) 
(Kwon et al., 2013). 
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In conclusion, the hTERT gene prolonged the usual life span of porcine 
fibroblasts into immortalized status. Immortalized cells with single cell 
survival properties were treated with TALE nucleases to delete CMAH. 
Then knocked out cells were employed to generate preimplantation embryos. 
These immortalized cells must become useful tools as an in vitro model to 
select the most effective TALEN pairs and KO specific genes to support 











GENETIC MODIFIED PIGS  
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Chapter I. Transgenic pigs overexpressing human SNCA. 
 
1. Introduction 
Among many chronic and progressive diseases afflicting humans, PD is 
the most common neurodegenerative movement disorder (Lees et al., 2009), 
that can affect 1% of people over age 60 (Dawson et al., 2010) and 4-5% of 
people over age 85 (Dawson and Dawson, 2002). Bradykinesia, muscle 
rigidity, tremor at rest and disturbances in balance are major symptoms of 
PD (Bohlhalter and Kaegi, 2011; Lang and Lozano, 1998a; Lang and 
Lozano, 1998b). PD is commonly associated with destruction of 
dopaminergic neurons in the substantia nigra pars compacta and is 
characterized by the presence of Lewy bodies in the intracytoplasmic 
regions (Yue and Lachenmayer, 2011). Genes that are related to PD are 
SNCA and LRRK2, autosomal dominant PD, PINK1, PRKN, and DJ-1, 
autosomal recessive PD (Blesa et al., 2012). The etiology of PD is unclear, 
however, the most common association of PD is an accumulation of 
aggregated SNCA in specific brain stem, spinal cord and cortical regions 
(Lees et al., 2009; Hawkes et al., 2010).  
Among those PD related genes, human SNCA, which is translated into a 
140 amino acid protein, exists naturally in an unfolded form. Nevertheless, 
folded forms of SNCA are frequently observed in Lewy bodies, the 
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hallmarks of neurodegenerative diseases such as PD (Brandt et al., 2008; 
Fearnley and Lees, 1991; Hawkes et al., 2010).  
Transgenic models for PD have been produced with overexpression of 
SNCA in many species, such as drosophila (Dawson et al., 2010), mice 
(Oliveras-Salva et al., 2013; Dawson et al., 2010), rats (Gombash et al., 
2013; Dawson et al., 2010) and monkeys (Eslamboli et al., 2007). However, 
the need for physiological similarity with humans as well as economic 
reasons necessitate development of alternative models for PD such as pigs 
(Glud et al., 2011; Swindle et al., 2012). 
Therefore, pigs were selected as the model animals in this study, and 
SNCA genes were randomly inserted into Yucatan kidney cells for 
introduction into oocytes of pigs via SCNT. The SCNT oocytes were then 
activated and cultured, then transferred into oviducts of surrogate pigs to 
produce offspring (Koo et al., 2009). The cloned pigs were analyzed by 





2. Materials and Methods 
2.1. Primary cell culture 
Adult female Yucatan kidney (16 months old) cells, which were used as 
control cells, were isolated and cultured. Kidneys were washed 3 times in 
PBS and then following the protocol previously established in our studies 
(Moon et al., 2014a). In brief, the washed kidney was chopped into small 
pieces with trypsin. Trypsinized tissues were then incubated for 30 min at 
37oC. Well dissociated tissues were centrifuged at 1,500 rpm for 2 min. The 
supernatant was discarded and the pellet was resuspended with PBS then 
centrifuged at 1,500 rpm for 2 min. These procedures were repeated 2 times. 
Finally, the supernatant was discarded and the pellet was resuspended in 
DMEM (Gibco, Carlsbad, California, USA) supplemented with 15% FBS 
(Gibco), 1% P/S (Gibco), 1% NEAA (Gibco) and 100 mM β-ME by 
inverting the tube several times. The cells resuspended in this medium were 
held at room temperature (around 25oC) for 5 min, then the suspension was 
transferred into a cell culture dish and cultured approximately 10 days with 
culture medium changes every 2-3 days. These primary cells were cultured, 
expanded and frozen at -196oC for further use. The cell cultures were 
maintained in DMEM with 15% FBS, 1% P/S, 1% NEAA and 100 mM β-
ME. 
 




 A plasmid, pLVC-SNCA-eGFP, containing a full-length human SNCA, was 
transfected into the experimental cells by viral infection (Supplementary 
Figure 1). In brief, the lentiviral vector was generated by co-transfection of 
Lenti X-293T (Clontech Laboratories, Inc., Otsu, Shiga, Japan; catalog no. 
632180) cells with Lenti X-HTX packaging mix (Clontech, catalog no. 
631260) using the calcium phosphate method. Virus particles were 
harvested 48 h post transfection. Virus producing cells were grown at 37oC, 
in a 5% CO2 incubator in high glucose DMEM supplemented with 10% 
tetracycline free fetal bovine serum, penicillin (100 U/ml), streptomycin 
(100 μg/ml), 0.1 mM MEM NEAA, 6 mM L-glutamine, and 1 mM MEM 
sodium pyruvate. The virus containing medium harvested from the virus 
producing cells was filtered through a 0.45 μm pore size filter before 
applying it to the Yucatan kidney cells for infection. After 16 h of 
incubation, the culture medium was changed and the cells were incubated 
for 2 additional days. Cells expressing eGFP were identified using 
fluorescence microscopy. 
 
2.3. PCR  
 Genomic DNA was extracted with the G-spin Genomic DNA Extraction 
Kit (iNtRON) according to the manufacturer’s protocol. Amplification of 
target genes was achieved using Maxime PCR PreMix (i-StarTaq, iNtRON). 
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Primer sets, conditions and expected sizes are annotated in Table 12. 
 
2.4. RT-PCR 
 Total RNAs were extracted to analyze gene expression in the immortalized 
cells by using the easy-spin Total RNA Extraction Kit (iNtRON). Then, 
cDNAs were synthesized using Maxime RT Premix (iNtRON) according to 
the manufacturer’s protocol.  
 Information on primers is listed in Table 12. Gene expression for SNCA 
was measured.  
 
2.5. SCNT and delivery of cloned piglets 
Transfected donor cells were subjected to SCNT, which was done by 
following the protocol established in our previous study (Koo et al., 2009). 
Briefly, immature oocytes were obtained from pig ovaries by aspiration of 
follicles and cultured for 40 h to support maturation. The in vitro matured 
(IVM) oocytes were enucleated using an aspiration pipette, then 
microinjected with an SNCA overexpressed donor cell, fused by electrical 
stimulation and activated using an electrical protocol. On day 2, 
reconstructed embryos were surgically transferred into the oviducts of 
recipient females. Pregnancy status was determined by ultrasonography on 
day 28 after ET. Cloned piglets were delivered by caesarean section and 
their clonal status was confirmed by PCR and RT-PCR based assays. 
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2.6. ELISA analysis 
 Blood samples were collected from the jugular veins of 4 month and 1 year 
control pigs with the same ages as the cloned pigs. Proteins were collected 
using PRO-PREPTM for Cell / Tissue Protein Extraction Solution (iNtRON 
biotechnology, Gyeonggido, Korea) according to the manufacturer’s 
protocol. Expressions of SNCA in 4 cloned pigs were evaluated with the α-
Synuclein Human ELISA Kit (Invitrogen, Carlsbad, California, USA) 
according to the manufacturer’s protocol. 
 
2.7. Analysis of SNCA pigs using a motor scoring system 
 The scoring analysis table for cloned pigs was based on UPDRS. The 
UPDRS is most broadly accepted clinical scale for the evaluation of PD 
patients (Ramaker et al., 2002). Motor scores of cloned pigs were 
accomplished 2 times (at 5 months of age and 1 year) by following our 
previously established protocol (Moon et al., 2014b). 
 
2.8. Statistical analysis 
 All data were analyzed by one way ANOVA followed by Tukey’s Multiple 
Comparison Test using GraphPad Prism version 5.01 (GraphPad Software, 
Inc., San Diego, California, USA) to determine differences among 
experimental groups. Statistical significance was determined when the p-




3.1. Production of SNCA expressing cells and blastocysts 
 A plasmid, pLVC-SNCA-eGFP, was constructed and transfected into cells 
via lentiviral infection (Figure 18). Before transfection, no cells expressed 
eGFP signals under UV. However, transfected cells that were selected by 
neomycin treatment showed eGFP expression (Figure 19B and B’). To 
confirm the suitability of donor cells for SCNT, transfected cells were 
inserted into oocytes and activated for development into blastocysts (Figure 
19C). Signals for eGFP were detected in fully developed blastocysts (Figure 
19C’).  
Insertion of SNCA, which is 194bp, in donor cells was identified by PCR 
(Figure 20A) and transcription of eGFP in donor cells was also confirmed 
by RT-PCR. In Figure 20B, the upper line indicates eGFP bands and the 
lower line indicates GAPDH bands. Both data ascertained that SNCA genes 
were well integrated into genomic DNAs and inserted genes were properly 
transcribed into messenger RNAs. Furthermore, transcription of SNCA in 
blastocysts was confirmed by RT-PCR (Figure 20C). 
 
3.2. Production of SNCA expressing piglets and its characteristics 
 Among 23 offspring, only 4 remain alive which are designated as PDF4, 
PDF16, PDF18 and PDF20 (the survival rate was 17.4% in this experiment.). 
Piglet PDF4 was born by caesarean section while the other 3 piglets were 
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born by normal full term delivery. Most of the dead piglets expressed eGFP 
under UV (data not shown). In piglet PDF2, strong expression of eGFP was 
detected in the whole body, intestine, heart, lung and brain. However, the 
expression level of eGFP was weak in spleen, liver, and kidney (Figure 21). 
 Moreover, genomic DNA integration of SNCA genes and their 
transcription were confirmed by PCR and RT-PCR. Among 23 piglets, it 
was confirmed in only one, PDF11, that the SNCA gene was not integrated 
into the genomic DNA. Nevertheless, while in 22 piglets existence of the 
SNCA gene was confirmed in genomic DNA, the SNCA gene was 
transcribed in only 11 piglets (PDF1, PDF2, PDF4, PDF6, PDF7, PDF16, 
PDF17, PDF18, PDF20, PDF21 and PDF22). Fortunately, four piglets 
(PDF4, PDF16, PDF18 and PDF20) that survived were identified as 
transgenic animals (Figure 25). 
 
3.3. Analysis of ELISA and motor scoring using SNCA expressing 
piglets 
 Over 1 year, ELISA was performed twice. At 4 months of age, SNCA 
concentrations in blood were measured: PDF4 (0.46 ± 0.01 ng/ml), PDF16 
(-0.06 ± 0.02 ng/ml), PDF18 (2.16 ± 0.04 ng/ml) and PDF20 (-0.04 ± 0.01 
ng/ml). Only PDF4 and PDF20 showed significant differences (p<0.05) 
when compared to control (Figure 22). However, SNCA concentrations in 
blood changed at 1 year of age: PDF4 (10.90 ± 0.17 ng/ml), PDF16 (0.23 ± 
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0.17 ng/ml), PDF18 (-0.13 ± 0.01 ng/ml) and PDF20 (5.75 ± 0.14 ng/ml). 
The SNCA blood concentrations of PDF4 and PDF20 significantly 
increased during year 1 after birth. However, SNCA concentrations in the 
blood of PDF18 significantly decreased during the first year after birth, 
while that of PDF16 did not significantly change.  
According to the scoring analysis, control pigs showed no change in score 
during the time points examined. The score for PDF18 decreased from ‘9’ to 
‘8’. However, after 7 months, scores increased from PDF4 (from ‘9’ to ‘13’), 





Figure 18. A schematic representation of pLVC-SNCA-eGFP. 
  




Figure 19. SNCA expression cells and blastocysts. (A and A’) Normal 
Yucatan kidney cell line. No expression of eGFP was detected. (B and B’) 
After transfection of pLVC-SNCA-eGFP in Yucatan kidney cells. eGFP 
expression was confirmed under UV. (C and C’) Blastocysts derived from 
pLVC-SNCA-eGFP transfected cells. eGFP expression was also established 










Figure 20. PCR and RT-PCR results for transfected cells and blastocysts. (A)  
Insertion of SNCA, which is 194bp, in donor cells identified by PCR (M; 
Marker, (+); Positive plasmid control, (-); Negative control, 1; Non-
transfected Yucatan kidney cells, 2; SNCA transfected Yucatan kidney cells). 
(B) Transcription of eGFP in donor cells was also confirmed by RT-PCR. 
Upper line indicates eGFP bands and lower line indicates GAPDH bands 
(M; Marker, (+); Positive plasmid control, (-); Non-transfected Yucatan 
kidney cells, V/R; pLVC-SNCA-eGFP viral RNA, 2; SNCA transfected 
Yucatan kidney cells). Both data ascertained that SNCA genes were well 
integrated into genomic DNAs and inserted genes were properly transcribed 
into messenger RNAs. (C) Transcription of SNCA in blastocysts was 
confirmed by RT-PCR (M; Marker, (+); Positive plasmid control, (-); 
SNCA 




    M       (+)      (-)        V         1      
A 
B 
 M    (+)     (-)     PA1    PA2   S1     S2 C 
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Negative control, PA1; 8 Parthenogenetic activated blastocysts, PA2; 
another 9 Parthenogenetic activated blastocysts, S1; 4 SNCA transfected 





Figure 21. Expression of eGFP in PDF2. Among 23 newly born piglets, 19 
died. All of the dead piglets were delivered to the laboratory for autopsy. 
Most of the dead piglets expressed eGFP under UV (data not shown). In 
PDF2, eGFP expression was highly detected in the whole body (A and A’), 
intestine (B and B’), heart (C and C’), lung (E and E’), and brain (G and G’). 
However, in spleen (D and D’), liver (F and F’), and kidney (H and H’) the 





















Figure 22. Detection of SNCA with ELISA in 4 month old (black bars) and 
1 year old pigs (grey bars). At 4 months old, SNCA concentrations in blood 
were measured; PDF4 (0.46 ± 0.01 ng/ml), PDF16 (-0.06 ± 0.02 ng/ml) 
PDF18 (2.16 ± 0.04 ng/ml), and PDF20 (-0.04 ± 0.01 ng/ml). Only PDF4 
and PDF20 showed significant differences (p<0.05) compared with control. 
However, SNCA concentrations in blood were altered at 1 year old; PDF4 
(10.90 ± 0.17 ng/ml), PDF16 (0.23 ± 0.17 ng/ml), PDF18 (-0.13 ± 0.01 
ng/ml), and PDF20 (5.75 ± 0.14 ng/ml). Using ELISA in 1 year old pigs, 
PDF4 and PDF20 showed significant differences (p<0.05) with control. 
Blood SNCA concentrations of PDF4 and PDF20 were significantly 
increased at 1 year after birth. However, blood SNCA concentrations of 
８９ 
 
PDF18 were significantly decreased 1 year after birth, while that of PDF16 





Figure 23. Scoring analysis for SNCA overexpression pigs. According to the 
scoring analysis for cloned pigs, control pigs showed unchanged scores over 
time. The score of PDF18 decreased from ‘9’ to ‘8’. However, scores of 
PDF4 (from ‘9’ to ‘13’), PDF16 (from ‘10’ to ‘11’), and PDF20 (from ‘6’ to 





















Figure 25. Detections of SNCA gene insertion and transcription. Genomic 
DNA integration of SNCA genes and their transcription were confirmed by 
PCR and RT-PCR, respectively, with tail samples. Among 23 piglets, it was 
confirmed in only one that the SNCA gene was not integrated into genomic 
DNA. Nevertheless, in 22 piglets it was confirmed that the SNCA gene was 
incorporated into the genomic DNA. Transcription of the SNCA gene was 
observed only in 11 piglets (PDF1, PDF2, PDF4, PDF6, PDF7, PDF16, 
PDF17, PDF18, PDF20, PDF21 and PDF22). Fortunately, four surviving 





Table 12. Details of primers used for PCR and RT-PCR. 
Gene 
Primer sequences (5’-3’) Size of PCR 
product (bp) 
GenBank 
accession no. Forward Reverse 
SNCA CTGAGAAAACCAAACAGGGTGT CTCCACTGTCTTCTGGGCTACT 194 AY049786 
eGFP GACTTCAAGGAGGACGGCAACA TCTCGTTGGGGTCTTTGCTCAG 256 U55762.1 




Transgenic animal PD models have been produced in many species 
including drosophila (Dawson et al., 2010), mice (Oliveras-Salva et al., 
2013; Dawson et al., 2010), rats (Gombash et al., 2013; Dawson et al., 2010) 
and monkeys (Eslamboli et al., 2007). However, no other PD model showed 
exactly the same disease progression as human PD patients. Because 
pathophysiological similarities exist between pigs and humans (Swindle et 
al., 2012; Glud et al., 2011), similar phenomena could be invoked after 
producing SNCA overexpression in pigs. The CMV promoter is a strong 
promoter which is mostly expressed in mammalian cells. Thus, our study is 
the first to produce pigs overexpressing the SNCA gene under the control of 
the CMV promoter. 
I produced 4 pigs via SCNT overexpressing SNCA. These cloned pigs were 
confirmed by PCR and RT-PCR, and I mainly focused on clinical signs in 
these pigs. Most of these cloned animals were asymptomatic. First, protein 
translation was observed over time by SNCA concentration using ELISA. 
Additionally, behavioral abnormalities were monitored by scoring analysis. 
Freichel et al. found that age dependent SNCA fibrillization in specific 
cortical regions was related to cognitive decline in SNCA transgenic mice 
(Freichel et al., 2007). In transgenic pigs overexpressing SNCA, similar 
results were obtained by comparing ELISA results to motor scoring analysis. 
In piglets PDF4 and PDF20, SNCA concentrations in blood significantly 
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increased with age. Correspondingly, the motor scoring analysis values 
increased. Otherwise, in the case of PDF18, SNCA concentrations in blood 
significantly decreased with age. Also, motor scoring analysis values 
decreased. Piglet PDF16 showed little change in SNCA concentrations with 
age, and a similar pattern was observed in the motor scoring analysis. Thus, 
I found that blood SNCA concentration changes were tightly correlated with 
motor scoring behavioral changes. Previous studies revealed that 1-methyl-
4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), neurotoxin, treated pigs 
showed abnormal behavior above a score of ‘11’ (Moon et al., 2014b). 
Piglets PDF4 and PDF16 had to be monitored intensively because their 
scores already exceeded ’11’. Additionally, piglets PDF18 and PDF20 were 
confirmed by PCR base analysis as cloned pigs. These two pigs also needed 
to be monitored carefully for abnormal behavioral changes. Extrapolating to 
human early onset familial PD patients’ ages, behavioral abnormalities can 
be detected several years later in pigs. Behavioral abnormalities and SNCA 
concentrations need to be continuously monitored for several years. Further 
studies using brain imaging systems; CT, MRI and PET-CT are planned. 
In conclusion, the cloned pigs overexpressing SNCA were successfully 
produced by SCNT. Among 23 cloned pigs produced, insertion of SNCA 
into genomic DNA was confirmed in 4 live pigs, in which correct 
transcription to messenger RNA was observed. Two cloned pigs showed 
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Chapter II. PRKN KO pig production via TALEN. 
 
1. Introduction 
PD is commonly emerged with destructions of dopaminergic neurons in 
substantia nigra pars compacta (Yue and Lachenmayer, 2011). Numerous 
genes are related with early onset PD (Autosomal dominant genes; SNCA, 
UCHL1, and LRRK2, autosomal recessive genes; PRKN, PINK1, DJ-1, and 
ATP13A2) (Blesa et al., 2012). In brief, autosomal dominant genes thought 
to cause PD, though autosomal recessive genes seemed to protect the 
neurons from toxic damages. 
Among those genes, PRKN gene, which translated into PRKN protein, was 
chosen for KO pig production. PRKN is the component of the multi-protein 
complex, E3 ubiquitin ligase. The function of PRKN is unclear but, it 
degrades toxic substances to dopaminergic neurons leads to decrease of 
those concentrations in neurons. Thus mutation in PRKN allows increasing 
of toxic damages to mitochondria in neurons, followed by malfunction and 
death of neurons (Dawson et al., 2010). Setting aside numerous causative 
factor modifications, only one protective gene KO was expected to 
asymptomatic pig production. Further cross breed with other gene modified 
pigs was important. 
Several previous studies revealed that KO by HR in pigs was effortful (Lai 
et al., 2002; Rogers et al., 2008; Suzuki et al., 2012). However, one of 
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emerging technologies, TALEN greatly improves KO efficiency (Xin et al., 
2013). 
Eight KO piglets were produced by combination of SCNT and TALEN 
technologies. Among them 3 were confirmed as a KO cloned piglets. 
However those KO piglets were dead on the day of birth with several 
reasons (e.g. cleft, stillbirth, and unclear reasons). The KO cell lines 
established from those piglets except stillbirth one. Further trials are 




2. Materials and Methods 
2.1. Primary cell culture 
Male Sinclair kidney cells, which were used as control cells, were isolated 
and cultured. Kidneys were washed 3 times in PBS and then following the 
protocol previously established in our studies (Moon et al., 2014).  
 
2.2. PARK2 KO using TALE nucleases 
Plasmids encoding TALENs that target exon of the pig PRKN gene and 
reporters for enrichment of TALEN mediated mutant cells used in this study 
were obtained from ToolGen Inc. (Seoul, Korea) (Kim et al., 2013b). For 
delivery of plasmids, 5x105 pig primary cells were electroporated using 
Neon device (Invitrogen) with a total of 5 μg DNA at a weight ratio of 2:2:1 
(plasmid encoding a left TALEN: plasmid encoding right TALEN: flow 
cytometer reporter) or 4.5:4.5:1 (Kim et al., 2011; Kim et al., 2013a), 
respectively. Both transfected cells were separately cultured for two days at 
37oC. Then those were checked under the inverted microscope by 
morphologically; size and shape. Then, suitable cells were selected between 
two cells before every SCNT without any selection. 
 
2.3. SCNT and delivery of KO piglets 
Selected high performance TALEN pairs and reporters are transfected into 
the Sinclair male kidney cells every week and used for SCNT donor cells 
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without any selection processes (e.g., antibiotic, fluorescent, and magnetic 
based selections). In brief, reporter itself has own RFP and out framed GFP. 
Thus if reporters are properly transfected into cells, RFP signals were 
detected. Coincidently, TALEN pairs are integrated into the cells, out 
framed GFP is frame shifted then GFP signal started to emit 2 to 3 days 
after transfection from both TALEN and reporter transfected cells.  
Only green fluorescence emitting cells were subjected to SCNT, which was 
done following the protocol previously established in our studies (Koo et al., 
2009). Briefly, immature oocytes were obtained from pig ovaries and 
cultured for 40 h to support maturation. The IVM oocytes were enucleated 
using an aspiration pipette, then microinjected with a control or transfected 
donor cell, fused by electrical stimulation and activated using an electrical 
protocol. On day 2, reconstructed embryos were surgically transferred into 
the recipient oviducts. The pregnancy condition was determined by 
ultrasonography on day 28 after ET. The cloned piglets were delivered by 
C-sec or normal childbirth. 
 
2.4. T7E1 assay 
After 48h of electroporation, genomic DNA was isolated from cells using 
ExgeneTM Cell SV mini kit (GeneAll Inc., Seoul, Korea). For validation of 
blastocysts, Blastocysts were pretreated with Direct PCR Lysis Reagent 
(Viagen Biotech Inc., California, USA) containing 0.4 mg/ml Proteinase K 
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at 55°C for 6h and then Proteinase K was inactivated at 85°C for 45min 
before the PCR reaction. Target locus was amplified using PRKN specific 
primer set and used for the T7E1 assay as previously described (Kim et al., 
2009). Briefly, the PCR amplicons were denatured and annealed to form 
heteroduplex DNA using a thermocycler and then digested with T7E1 




For sequencing analysis, PCR products corresponding to genomic 
modifications were purified and cloned into the T-Blunt vector (SolGent 
Inc., Daejeon, Korea). Target DNA samples were delivered to a sequencing 
company (Macrogen Ltd., Seoul, Korea). Briefly, sequencing reactions were 
performed in the DNA Engine Tetrad 2 Peltier Thermal Cycler (BIO-RAD) 
using the ABI BigDye (R) Terminator v3.1 Cycle Sequencing Kit (Applied 
Biosystems), following the protocols supplied by the manufacturer. Single-
pass sequencing was performed on each template using a M13 primer. The 
fluorescent labeled fragments were purified by the method recommended by 
Applied Biosystems because it removes unincorporated terminators and 
dNTPs. The samples were subjected to electrophoresis in an ABI 3730xl 




3.1. Production of PRKN KO blastocysts 
Only GFP expressing cells with under the size of 20 μm and compact 
round shaped cells were chosen for SCNT. Before ET into recipient, KO 
efficiencies were check from cloned embryos. Eleven KO embryos were 
observed from total 37 embryos by T7E1 assay (KO efficiency rate; 30.0%) 
(Figure 27). 
 
3.2. Production of PRKN KO piglets via SCNT 
Among 14 recipients, 6 mothers (pregnancy rate; 42.9%) were pregnant at 
day 28 after ET with sonography. Four recipient (delivery rate; 28.6%) gave 
birth to 8 offspring those names were PDM1 to PDM8. PDM1 and PDM2 
were delivered by C-sec from one mother, PDM3 to PDM6 were delivered 
by C-sec from another mother, PDM7 were delivered by C-sec from the 
third mother, and PDM8 were delivered by natural delivery from the last 
mother (Table 13). Among the 8 cloned piglets, PDM1 (live), PDM2 
(euthanasia because of cleft), PDM4 (live), PDM7 (dead with unclear 
reason), and PDM8 (dead with unclear reason) were confirmed that normal 
piglets. Except them, 3 (PDM3; heterozygote; WT:AàG/-7, PDM5; 
homozygote; -4/+7, PDM6; homozygote; -78/-14) were confirmed that KO 
cloned piglets by sequencing analysis (Figure 28). The KO efficiency rate 
was 37.5% in this experiment. However these 3 KO pigs were all dead on 
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the day of birth (PDM3; unclear reason, PDM5; euthanasia because of cleft, 
and PDM6; stillbirth) (Table 14). 
 Even cell lines could not be established in PDM6 because of stillbirth, but 
PDM3 and PDM5 cell lines were cultured and cryopreserved, including cell 






Figure 26. PRKN TALEN and reporter transfected cell lines. A, A’, and A’’ 
are pictures of randomly selected one site of TALEN and reporter 
transfected cell lines, and B, B’, and B’’ are pictures of another randomly 
selected one site of TALEN and reporter transfected cell lines with same 
electroporation conditions (Cell type; Sinclair male kidney, Cell number; 
5×105 cells, Total amount of DNA; 5 μg (TALEN left: TALEN Right: 
Reporter = 2:2:1)). (A and B) TALEN and reporter transfected cell lines 
under the inverted microscope. (A’ and B’) Reporter gene inserted cells 
expressed RFP signals under the fluorescence microscope. (A’’ and B’’) 





Figure 27. T7E1 assay result of SCNT derived embryos. Among 37 cloned 
embryos, 11 embryos (red colored) were confirmed as KO embryos by 




Figure 28. Sequencing results from PDM1 to PDM8. Compared to wild type, 
PDM1, PDM2, PDM4, PDM7, and PDM8 showed same sequences. PDM3 
(heterozygote) showed 7 bps deletions in one allele, and A to G substitution 
was observed in another allele but wild type. PDM5 (homozygote) showed 
4 bps deletions and 7 bps insertions in each alleles, and PDM6 (homozygote) 





Table 13. Delivery methods and number of offspring for PRKN KO cloned 
pigs 
No. ID Target gene No. of offsprings Delivery methods 
1 Y27-4 PRKN KO 2 C-sec* 
2 D4-3 PRKN KO 4 C-sec* 
3 496 PRKN KO 1 C-sec* 





Table 14. Current status of PRKN cloned piglets 
ID Modified genes Sex Fate Cause of death 
PDM1 None* M** Alive - 
PDM2 None* M** Dead Cleft 
PDM3 Hetero PRKN KO M** Dead Unclear reason 
PDM4 None* M** Alive - 
PDM5 Homo PRKN KO M** Dead Cleft 
PDM6 Homo PRKN KO M** Dead Stillbirth 
PDM7 None* M** Dead Unclear reason 
PDM8 None* M** Dead Unclear reason 







I could produce PRKN KO pigs with highly selected TALEN pairs and 
reporters with no selection processes (e.g., antibiotic, fluorescent, and 
magnetic based selections.). After selection procedures, cells were much 
damaged (Jang et al., 2006). These damaged cells were not appropriate for 
SCNT donors. Whole selection methods (e.g., antibiotic selection, 
fluorescence activated cell sorting (FACS), or magnetic activated cell 
sorting (MACS)) could damage to cells. MACS method gave the least 
damages to cells. However, in MACS, H-2Kk proteins were artificially 
introduced to the surface of cells (Kim et al., 2013a), which hindered the 
fusion of oocyte cytoplasm to donor cell cytoplasm during SCNT (data not 
shown). Without selection processes, enrichment of KO cells were difficult. 
High performance TALEN pairs were selected to overcome this hurdle, and 
then knocked out cells were conveniently chosen under the UV microscope 
as donor cells for SCNT. 
In conclusion, PRKN KO pigs were produced with SCNT combined with 
high performance TALEN without specific selection procedures. Three out 
of 8 pigs were confirmed as PRKN KO pigs by T7E1 and sequencing. 
Except stillbirth pig (PDM6), other PRKN KO pig cell lines were 














Firstly, hTERTs were randomly inserted pig cell line was established. 
These cell line was qualified by PCR based assay, karyotyping, sequencing, 
single cell colony formation assay, and telomerase activity test and so on. 
Finally I established exogenous gene overexpression cell line in pig. 
CMAH and GGTA1, those were related with hyperacute rejection of pig 
organs to transplant into human body, were selected as KO targets. Each 
gene was knocked out separately. The knocked out cells were established 
and confirmed by sequencing, T7E1, fPCR, and FACS.  
Nextly, these techniques, which worked properly in in vitro, were applied 
to in vivo transgenic pig production. Target genes, SNCA and PRKN, were 
selected to produce disease model pig. SNCA was well known gene for 
causative factor in PD. In contrast, PRKN was well known gene for 
protective factor in PD. Thus I scheduled to overexpress SNCA and PRKN 
KO. The SNCA overexpressed pigs were produced and confirmed by PCR, 
RT-PCR, ELISA, and motor scoring analysis. PRKN knocked out pigs were 
also delivered and confirmed by T7E1 and sequencing.  
In conclusion, I demonstrated that immortalized porcine fibroblasts were 
successfully established using the human hTERT gene and the TALENs 
enabled gene disruptions (CMAH and GGTA1) in these immortalized cells 
in vitro. Additionally, these transfected cells also developed into the 
blastocyst stages via SCNT. Based on these in vitro studies, SNCA 
overexpressed pigs and PRKN KO pigs were successfully produced. The 
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live SNCA overexpressed pigs were determined as transgenic animals by 
PCR based analysis, however due to young age, only 1 year old pigs, 
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 현재까지 가장 이상적인 형질전환돼지를 생산하는 방법은 
형질전환된 체세포를 핵이 제거된 난자에 주입하는 방법이다. 
대부분의 형질전환돼지는 상대적으로 선별과정이 덜 복잡한 목적 
유전자를 과발현하는 돼지이고 유전자 적중 방법으로 생산된 
돼지의 수는 적다. 하지만 최근에 다양한 유전자 가위들 (즉, 
ZFN, TALEN, 또는 RGEN)이 각광을 받기 시작하면서 
중대동물 형질전환 분야에서도 돼지를 포함한 다양한 종류의 
유전자 적중된 동물들이 태어나기 시작했다.  
돼지는 생물의학 연구에 있어서 중요한 동물모델이다. 하지만 
배아줄기세포와 특성화된 세포주가 존재하지 않기 때문에 
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형질전환기술 개발과 형질전환동물 생산의 속도가 더디다. 본 
연구에서는, 돼지의 특성화된 세포주가 존재하지 않는 점을 
극복하기 위하여 hTERT 유전자를 과발현시킨 불멸화세포주를 
확립하고 특성화하였다. 또한 이 세포를 이용하여 형질전환기술 
즉, TALEN 을 통한 유전자 적중을 추가적으로 적용하였다. 
이러한 유전자 과발현 기술과 유전자 적중 기술을 사용하여 
각각의 형질전환돼지, 그 중에서도 신경질환돼지모델을 
생산하였다.  
본 연구에서는 돼지체세포를 불멸화하기 위해서 돼지 태아 
섬유아세포를 분리하여 배양하였고 hTERT 를 전기적인 방법을 
이용하여 세포 내로 도입하였다. Neomycin 을 이용하여 2 주간 
형질전환된 세포를 선별하였고, 선별한 세포를 계대배양하였다.  
목적 유전자가 돼지체세포에서 적절하게 발현하는지를 다양한 
방법으로 확인하였다. 불멸화 돼지세포는 배가시간 (doubling 
time)이 대략 24 시간, 세포의 크기 역시 20 μm 이하로 최소 
9 개월 이상 유지되는 것을 확인하였다. 하지만 같은 기간 동안 
대조군 세포는 노화하여 더 이상 분열하지 못하는 것을 
관찰하였다. 또한 불멸화 세포는 단 하나의 세포에서 100 mm 
배양접시를 가득 채울 만큼 분열할 수 있는 능력이 있다는 것도 
확인할 수 있었다.  
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이렇게 목적 유전자의 과발현 여부를 확인한 세포에 유전자 가위 
중 하나인, TALEN 을 이용하여 CMAH 유전자를 적중시킨 
세포주를 확립하였다. 개개의 colony 중에서 CMAH 유전자가 
적중된 세포주를 확정하기 위해서 T7E1 를 진행하였고, fPCR 과 
sequencing 을 통해서 그 중 3 개의 biallelic 유전자 적중 
세포주를 확인하였다. GGTA1 유전자 적중도 위와 동일한 
방법으로 진행하였다. 이렇게 만들어진 hTERT 유전자 과발현과 
CMAH 유전자 적중이 동시에 된 세포주 중 하나를 이용해서 
체세포 핵이식을 진행하였고, 여러 유전자가 조작된 세포주도 
정상적으로 배반포까지 자라남을 증명하였다. 
목적 유전자 과발현 및 적중된 형질전환돼지를 실제로 생산하기 
위해서 파킨슨병과 관련된 유전자 중 SNCA 와 PRKN 을 각각 
선별하였다.  
먼저 SNCA 가 과발현하는 돼지 23 마리를 체세포 핵이식 
기법으로 만들었다. 하지만 불명확한 이유로 현재는 4 마리만 
살아있고, 그 4 마리 모두 형질전환동물임이 PCR 과 RT-
PCR 을 통해 확인되었다. SNCA 단백질 발현 여부도 ELISA 를 
이용해서 태어난 지 4 개월령에 실시하였을 당시 2 마리 
(PDF4 와 PDF18)에서만 단백질 발현이 확인되었다. 하지만 
단백질 발현의 정도는 1 년령이 되면서 변화하였고, PDF4 와 
１３９ 
 
PDF20 은 SNCA 의 발현이 유의적으로 증가한 반면, 
PDF18 에서는 감소하였고, PDF16 은 변하지 않는 것을 
확인하였다.  또한 행동학적 이상을 판단하기 위해 행동학적 
분석을 대조군과 모든 형질전환돼지에서 5 개월령과 1 년령에 
실시하였다 (대조군, 변화없음; PDF18, 감소; PDF4, PDF16, 
and PDF20, 증가; PD 유사행동을 보일 경우 수치가 증가). 그 
결과 단백질 발현의 변화 유무와 행동학적인 이상 유무가 
유사하게 나타나는 경향이 있다는 것을 확인하였다.   
다음으로, 유전자 적중 돼지 생산을 위해 PRKN 을 선별하였다. 
PRKN 유전자를 자르는 TALEN 쌍을 리포터와 함께 
돼지체세포에 주입하였고, 별다른 선별과정 없이 형질전환 2~3 일 
후 초록색 형광빛을 발하는 세포만을 이용하여 체세포 핵이식을 
진행하였다. 총 8 마리의 산자 (Parkinson’s disease male 
pig model; PDM1~8)가 태어났고, 이 중 3 마리 (PDM3; 
heterozygote, PDM5; homozygote, 그리고 PDM6; 
homozygote)가 T7E1 과 sequencing 을 통해서 최종적으로 
확인되었다. 태어난 유전자 적중 돼지는 현재 모두 폐사한 
상태이다 (PDM3; 사인불명, PDM5; 구개열로 안락사, 그리고 
PDM6; 사산). 사산으로 태어나서 세포의 확립이 불가능했던 
PDM6 를 제외한 나머지 2 마리의 유전자 적중 돼지에서 
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세포주를 확립하여 보관하고 있다. 현재 추가적으로 같은 
유전자를 가진 돼지를 생산하기 위해 노력하고 있다.  
결론적으로, 실험실 내에서 hTERT 유전자가 과발현된 불멸화 
세포를 확립할 수 있었고, TALEN 을 이용하여 CMAH 유전자를 
불멸화 세포에서 적중할 수 있었다. 추가적으로 이렇게 
형질전환된 체세포도 체세포 핵이식에 공여세포로 사용이 
가능함을 증명하였다. 이러한 방법적인 연구를 토대로, 실제로 
SNCA 가 과발현하는 돼지와 PRKN 이 적중된 돼지를 
생산하였다. 현재 살아있는 SNCA 과발현 돼지와 추후 재생산할 
PRKN 적중돼지에 대해서는 추가적인 단백질 분석, 행동학적 
분석, 그리고 뇌영상학적 분석등이 진행될 예정이다. 
주요어: 형질전환동물, 체세포 핵이식, 유전자 과발현, 유전자 
적중 
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